Avascular Necrosis Market Size: $1.1B by 2033
As knowledge expands, so do treatment options. Patients are witnessing a diverse array of approaches, ranging from pharmacological therapies, such as NSAIDs and cholesterol-lowering medications, to innovative surgical methods, including core decompression and joint replacements. North America is currently at the forefront of this market, thanks to its cutting-edge healthcare infrastructure.